Your browser doesn't support javascript.
loading
Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.
Dalal, Suhani; Chitneni, Ahish; Berger, Amnon A; Orhurhu, Vwaire; Dar, Bilal; Kramer, Bennett; Nguyen, Anvinh; Pruit, John; Halsted, Charles; Kaye, Alan D; Hasoon, Jamal.
Afiliação
  • Dalal S; A.T. Still University School of Medicine.
  • Chitneni A; A.T. Still University School of Medicine.
  • Berger AA; Beth Israel Deaconess Medical Center and Harvard Medical School.
  • Orhurhu V; University of Pittsburgh Medical Center.
  • Dar B; Brigham and Women's Hospital and Harvard Medical School.
  • Kramer B; Massachusetts General Hospital and Harvard Medical School.
  • Nguyen A; Baylor College of Medicine.
  • Pruit J; Baylor College of Medicine.
  • Halsted C; Baylor College of Medicine.
  • Kaye AD; Louisiana State University Health Sciences Center.
  • Hasoon J; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; Department of Anesthesiology, Baylor College of Medicine.
Health Psychol Res ; 9(1): 27241, 2021.
Article em En | MEDLINE | ID: mdl-34746493
With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article